Organogenesis Appoints David C. Francisco as Chief Financial Officer
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Organogenesis Appoints David C. Francisco as Chief Financial Officer Organogenesis Holdings Inc.February 16, 2021 GMT CANTON, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, announces the appointment of David C. Francisco as the Company’s Chief Financial Officer, effective...